Published in Lupus on March 20, 2012
Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep (2012) 0.90
Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med (2014) 0.86
Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption. Osteoporos Int (2013) 0.85
Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare. Clin J Am Soc Nephrol (2015) 0.84
Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis. Proteomics Clin Appl (2015) 0.79
The role of vitamin D supplementation in patients with rheumatic diseases. Nat Rev Rheumatol (2013) 0.78
Vitamin D Levels Are Associated with Expression of SLE, but Not Flare Frequency. Int J Rheumatol (2014) 0.77
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Ann Rheum Dis (2016) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med (2008) 7.21
Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab (1988) 7.09
Clinical practice. Vitamin D insufficiency. N Engl J Med (2011) 6.84
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr (1998) 4.55
A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med (1992) 4.33
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol (2001) 4.06
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 3.49
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest (1983) 3.41
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Vitamin D: modulator of the immune system. Curr Opin Pharmacol (2010) 3.31
Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int (2008) 2.95
Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol (2004) 2.73
25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes (2007) 2.58
Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol (2004) 2.49
Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol (2008) 2.47
25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension (2010) 2.33
Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int (2005) 2.19
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.14
Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol (2009) 2.13
Vitamin D and African Americans. J Nutr (2006) 2.12
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A (2008) 2.06
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) (2011) 1.70
1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest (1996) 1.65
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int (2007) 1.64
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab (2010) 1.64
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum (1998) 1.58
Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood (2003) 1.47
Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int (2010) 1.47
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int (2008) 1.36
Seasonal variation in vitamin D. Proc Nutr Soc (1994) 1.29
Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol (2008) 1.29
Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int (2011) 1.27
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum (2003) 1.21
Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol (2009) 1.19
Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol (2010) 1.18
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int (2008) 1.14
The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol (2009) 1.07
Vitamin D and cardiovascular disease risk: emerging evidence. Curr Opin Cardiol (2010) 1.06
The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep (2008) 1.00
The dualistic role of vitamin D in vascular calcifications. Kidney Int (2010) 0.98
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications. Clin J Am Soc Nephrol (2008) 0.97
Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy. Kidney Int (2005) 0.97
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum (2006) 0.96
Vitamin D: the alternative hypothesis. Autoimmun Rev (2009) 0.93
Ultraviolet light and cutaneous lupus. Lupus (2006) 0.91
Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol (2002) 0.89
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats. Nephrol Dial Transplant (2008) 0.84
Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature. Eur J Clin Invest (2005) 0.83
Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology (1997) 7.81
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell (1999) 5.07
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry (2002) 2.97
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med (2000) 2.77
Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci U S A (2001) 2.66
Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat Genet (1998) 2.26
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
Electrical activity modulates growth cone guidance by diffusible factors. Neuron (2001) 2.14
Timing of prenatal stressors and autism. J Autism Dev Disord (2005) 2.02
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2001) 1.88
Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol (2001) 1.87
Evaluation of methods to assess physical activity in free-living conditions. Med Sci Sports Exerc (2001) 1.82
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Mosaic autosomal trisomy in cultures from spontaneous abortions. Am J Hum Genet (1978) 1.80
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Subgingival microbial profiles of smokers with periodontitis. J Dent Res (2010) 1.70
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob Agents Chemother (1998) 1.69
Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release. J Immunol (1998) 1.67
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Phospholipase C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signaling in nerve growth cone guidance. Neuron (1999) 1.65
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology (2005) 1.63
Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology (1999) 1.62
OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol (1998) 1.59
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J (1986) 1.54
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Tree-based linkage and association analyses of asthma. Genet Epidemiol (2001) 1.52
The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics (1994) 1.52
A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene (2009) 1.50
Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles. Immunogenetics (1987) 1.49
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br J Cancer (2005) 1.48
Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole. J Clin Microbiol (1999) 1.46
Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int (2000) 1.46
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem (2001) 1.43
Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry (2011) 1.39
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer (2008) 1.38
Human helicase gene SKI2W in the HLA class III region exhibits striking structural similarities to the yeast antiviral gene SKI2 and to the human gene KIAA0052: emergence of a new gene family. Nucleic Acids Res (1995) 1.37
X-ray crystal structure of the yeast Kar3 motor domain complexed with Mg.ADP to 2.3 A resolution. Biochemistry (1998) 1.35
Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J Neurosci (1998) 1.32
G alpha 13 stimulates Na+-H+ exchange through distinct Cdc42-dependent and RhoA-dependent pathways. J Biol Chem (1996) 1.32
Identification, detection, and spatial resolution of Clostridium populations responsible for cellulose degradation in a methanogenic landfill leachate bioreactor. Appl Environ Microbiol (2004) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Comparisons of four methods of estimating physical activity in adult women. Med Sci Sports Exerc (2000) 1.29
Polymorphism of human complement component C4. Immunogenetics (1985) 1.28
Genetic control of horizontal virus transmission in the chestnut blight fungus, Cryphonectria parasitica. Genetics (2001) 1.28
Complement component C4 gene intron 9 as a phylogenetic marker for primates: long terminal repeats of the endogenous retrovirus ERV-K(C4) are a molecular clock of evolution. Immunogenetics (1995) 1.28
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J Biol Chem (2000) 1.27
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol (2001) 1.23
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Antimicrob Agents Chemother (1997) 1.23
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
A case-control study of anterior cruciate ligament volume, tibial plateau slopes and intercondylar notch dimensions in ACL-injured knees. J Biomech (2010) 1.22
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology (2007) 1.21
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Comparison of PCR and culture to the indirect fluorescent-antibody test for diagnosis of Potomac horse fever. J Clin Microbiol (1997) 1.20
Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton) (2005) 1.20
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer (2009) 1.19
A comparative analysis of mitochondrial genomes in Coleoptera (Arthropoda: Insecta) and genome descriptions of six new beetles. Mol Biol Evol (2008) 1.19
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene. Oncogene (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Common variants in mismatch repair genes and risk of colorectal cancer. Gut (2008) 1.17
The spatial relationship between infant mortality and birth defect rates in a U.S. city. Stat Med (1997) 1.16
Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology (2003) 1.14
Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology (2000) 1.14
Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem (2001) 1.14
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
High-surface-area catalyst design: Synthesis, characterization, and reaction studies of platinum nanoparticles in mesoporous SBA-15 silica. J Phys Chem B (2005) 1.10
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis (1997) 1.09
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer (2009) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Implantation: molecular basis of embryo-uterine dialogue. Int J Dev Biol (2001) 1.07
Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med (1998) 1.07
Renal tubular acidosis complicated with hypokalemic periodic paralysis. Pediatr Neurol (1995) 1.07
Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun (2009) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther (2002) 1.06
The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus. Oncogene (2013) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Molecular identification of IgE-dependent histamine-releasing factor as a B cell growth factor. J Immunol (2001) 1.06
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. J Antimicrob Chemother (1998) 1.05